logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Ascletis Pharma-B (01672.HK) repurchased 200,000 shares for approximately HK$1.2025 million on October 16.

date
16/10/2026
Zhitong Finance APP news, Ascletis Pharma-B (01672.HK) announced that on October 16, 2026, the company spent approximately HK$1.2025 million to repurchase 200,000 shares at a repurchase price of HK$5.835 to HK$6.215 per share.
Latest
now
Xinrui Shares (688257.SH) issued a profit forecast increase, expecting net profit attributable to shareholders for the first three quarters of 690 million yuan to 750 million yuan, a year-on-year increase of 318% to 355%.
1 m ago
New Stock News | Dongshan Precision (002384.SZ) Hong Kong IPO Receives Filing with the CSRC
2 m ago
New Stock News | Youibot's Hong Kong IPO and Full Circulation of Domestic Unlisted Shares Filed with the CSRC
3 m ago
U.S. dollar bond movement | Kaisa Group KAISAG 6.25 12/28/28 price rose 4.904%, quoted at 1.230
3 m ago
USD Bond Movement | South China City CSCHCN 9 04/12/24 price fell 2.58% to 24.071.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.